Celldex Therapeutics (CLDX) Receivables (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Receivables of $230000.0 for Q1 2026, down 78.38% year-over-year from $1.1 million in Q1 2025, and down 88.59% quarter-over-quarter from $2.0 million in Q4 2025.
Celldex Therapeutics (CLDX) Receivables (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Receivables history runs 17 years deep, the most recent figure standing at $230000.0 for Q1 2026.
- In Q1 2026, Receivables fell 78.38% year-over-year to $230000.0; the TTM figure through Mar 2026 stood at $230000.0 (down 78.38% YoY), while the FY2025 annual figure was $2.0 million, up 187.86% from the prior year.
- Receivables for Q1 2026 stood at $230000.0, down from $2.0 million in the prior quarter.
- The five-year high for Receivables was $2.7 million in Q1 2024, with the low at $90000.0 in Q2 2025.
- The 5-year median for Receivables is $247500.0 (2022), against an average of $768500.0.
- The sharpest annual moves came in 2024 and 2025: Receivables surged 1200.0% in 2024, then plunged 94.13% in 2025.
- Celldex Therapeutics' Receivables stood at $189000.0 in 2022, then jumped by 33.33% to $252000.0 in 2023, then soared by 238.1% to $852000.0 in 2024, then soared by 136.5% to $2.0 million in 2025, then sank by 88.59% to $230000.0 in 2026.
- Business Quant data shows CLDX's Receivables at $230000.0 in Q1 2026, $2.0 million in Q4 2025, and $90000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 230,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 230,000.00 |
| Mar 31, 2026 | 230,000.00 |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 90,000.00 |
| Mar 31, 2025 | 1.06 Mn |
| Sep 30, 2024 | 852,000.00 |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Sep 30, 2023 | 252,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Sep 30, 2022 | 189,000.00 |
| Jun 30, 2022 | 97,000.00 |
| Mar 31, 2022 | 243,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Jun 30, 2021 | 496,000.00 |
| Mar 31, 2021 | 1.83 Mn |
| Dec 31, 2020 | 1.80 Mn |